Innovation Center of NanoMedicine (Center Director: Prof. Kazunori Kataoka) has announced that Prof. Satoshi Uchida (Principal Research Scientist), who is also Associated Professor of the Kyoto ...
Increased demands for plasmid DNA (pDNA) for emerging nucleic acid-based vaccines and therapies exacerbate the need to remove bottlenecks from pDNA production. For industry, the problem has been that ...
High-throughput virology, design of experiments, and small-molecule production enhancers optimize yield and increase ...
Researchers have controlled the evolution of E. coli bacteria in the lab in order to dramatically increase the amount of plasmid DNA (pDNA) these modified bacteria produce. The advance is significant ...
Successful gene therapy using plasmid DNA (pDNA) relies on the development of nonviral vectors that can deliver pDNA to cell nuclei. Most of these vectors are either cationic polymers or their ...
Circular double-stranded plasmid DNA (pDNA) plays a crucial role in vaccine development, cell and gene therapy, and recombinant protein or mAb production. These small pieces of DNA carry targeted ...
Plasmid DNA is critical for cell and gene therapies, but scaling high-purity production remains challenging as CDMO partners deliver the agility needed.
Located less than 30 miles north of Houston, Texas, the new facility designs, develops and manufactures research-grade pDNA materials to support the cell and gene therapy field. With the global ...
The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...
HOUSTON, August 12, 2025--(BUSINESS WIRE)--Bionova Scientific ®, a full-service biologics contract development and manufacturing organization (CDMO) and subsidiary of global conglomerate Asahi Kasei, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results